. 2017 Apr 28;23(16):2854–2869. doi: 10.3748/wjg.v23.i16.2854

Table 2.

Eradication rates achieved with susceptible guided therapy as first treatment and rescue treatment

Line of therapy	Ref.	Type of therapy	Patients (n)	Methods	Tailored therapy eradication rates
Line of therapy	Ref.	Type of therapy	Patients (n)	Methods	ITT %	PP %
First Line	Liu et al[83], 2015	RpzBAC, RpzBAF	89	Real-time PCR	98 in RpzBAC group	100 in RpzBAC group
First Line	Liu et al[83], 2015	RpzBAC, RpzBAF	89	Real-time PCR	92.6 in RpzBAF group	94 in RpzBAF group
First Line	Sugimoto et al[90], 2014	RpzAC, RpzAM	153	PCR	96.7 (overall)	97.4 (overall)
Third line	Liou et al[89], 2013	Sequential triple	135	PCR and Agar dilution	80.7	82.6
Fourth	Fiorini et al[91], 2013	Triple (EAC, EAR)	236	E-test	NR	90 in EAC
Fourth	Fiorini et al[91], 2013	Triple (EAC, EAR)	236	E-test	NR	88.6 in EAR

B: Bismuth potassium citrate; Rpz: Rabeprazole; A: Amoxicillin; C: Clarithromycin; F: Furazolidone; M: Metronidazole; R: Rifabutin; E: Esomeprazole; NR: Not reported.